Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders.
作者信息
Zarate C A, Machado-Vieira R
机构信息
Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
出版信息
Mol Psychiatry. 2017 Mar;22(3):324-327. doi: 10.1038/mp.2016.249. Epub 2017 Jan 10.
Abstract
摘要
相似文献
1
Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders.氯胺酮：将机制性发现转化为用于治疗情绪障碍的新一代谷氨酸调节剂。
Mol Psychiatry. 2017 Mar;22(3):324-327. doi: 10.1038/mp.2016.249. Epub 2017 Jan 10.
2
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.谷氨酸在情绪障碍中的作用：氯胺酮治疗重度抑郁症研究的结果及其抗抑郁作用的潜在细胞机制。
Curr Psychiatry Rep. 2007 Dec;9(6):467-74. doi: 10.1007/s11920-007-0063-1.
3
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.氯胺酮与速效抗抑郁药：开启情绪障碍治疗新神经生物学的一扇窗。
Annu Rev Med. 2015;66:509-23. doi: 10.1146/annurev-med-053013-062946. Epub 2014 Oct 17.
4
Glutamate modulators as novel interventions for mood disorders.谷氨酸调节剂作为情绪障碍的新型干预手段。
Braz J Psychiatry. 2005 Sep;27(3):243-8. doi: 10.1590/s1516-44462005000300016. Epub 2005 Oct 4.
5
The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.三突触谷氨酸能突触在心境障碍的病理生理学和治疗学中的作用。
Neuroscientist. 2009 Oct;15(5):525-39. doi: 10.1177/1073858409336093. Epub 2009 May 26.
6
Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.右美沙芬/奎尼丁的作用机制：与氯胺酮的比较。
CNS Spectr. 2013 Oct;18(5):225-7. doi: 10.1017/S109285291300062X.
7
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.氯胺酮及其他谷氨酸受体调节剂用于成人双相情感障碍的抑郁治疗
Cochrane Database Syst Rev. 2015 Sep 29(9):CD011611. doi: 10.1002/14651858.CD011611.pub2.
8
Ketamine and Other Glutamate Receptor Modulators for Depression in Bipolar Disorder in Adults.氯胺酮及其他谷氨酸受体调节剂用于成人双相情感障碍的抑郁治疗
Issues Ment Health Nurs. 2017 Jun;38(6):526-527. doi: 10.1080/01612840.2017.1322427.
9
Glutamatergic modulators: the future of treating mood disorders?谷氨酸能调节剂：治疗心境障碍的未来？
Harv Rev Psychiatry. 2010 Sep-Oct;18(5):293-303. doi: 10.3109/10673229.2010.511059.
10
[Ketamine for treatment of acute depression].[氯胺酮用于治疗急性抑郁症]
Ugeskr Laeger. 2013 Sep 9;175(37):2090-3.
引用本文的文献
1
Multidimensional Effects of Stress on Neuronal Exosome Levels and Simultaneous Transcriptomic Profiles.应激对神经元外泌体水平及同步转录组图谱的多维影响。
Biol Psychiatry Glob Open Sci. 2024 Oct 5;5(1):100401. doi: 10.1016/j.bpsgos.2024.100401. eCollection 2025 Jan.
2
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders.抗抑郁药衍生物合成的最新进展：情绪障碍的药理学见解
3 Biotech. 2024 Nov;14(11):260. doi: 10.1007/s13205-024-04104-5. Epub 2024 Oct 5.
3
Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol.氯胺酮增强的延长暴露疗法治疗 PTSD 退伍军人：一项随机对照试验方案。
Contemp Clin Trials. 2024 Aug;143:107569. doi: 10.1016/j.cct.2024.107569. Epub 2024 May 9.
4
Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expression.羟基去甲氯胺（羟考酮）而非氯胺酮通过α7 型烟碱型乙酰胆碱受体来控制突触前功能和基因表达。
Transl Psychiatry. 2024 Jan 22;14(1):47. doi: 10.1038/s41398-024-02744-y.
5
Oral ketamine may offer a solution to the ketamine conundrum.口服氯胺酮可能为氯胺酮难题提供解决方案。
Psychopharmacology (Berl). 2023 Dec;240(12):2483-2497. doi: 10.1007/s00213-023-06480-x. Epub 2023 Oct 26.
6
Right Frontal Theta: Is It a Response Biomarker for Ketamine's Therapeutic Action in Anxiety Disorders?右额叶θ波：它是氯胺酮治疗焦虑症的反应生物标志物吗？
Front Neurosci. 2022 Jul 4;16:900105. doi: 10.3389/fnins.2022.900105. eCollection 2022.
7
Ketamine induces opposite changes in AMPA receptor calcium permeability in the ventral tegmental area and nucleus accumbens.氯胺酮诱导腹侧被盖区和伏隔核中 AMPA 受体钙通透性的相反变化。
Transl Psychiatry. 2021 Oct 14;11(1):530. doi: 10.1038/s41398-021-01658-3.
8
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.新型谷氨酸能调节剂治疗心境障碍的研究进展
CNS Drugs. 2021 May;35(5):527-543. doi: 10.1007/s40263-021-00816-x. Epub 2021 Apr 26.
9
The role of dissociation in ketamine's antidepressant effects.分离在氯胺酮抗抑郁作用中的作用。
Nat Commun. 2020 Dec 22;11(1):6431. doi: 10.1038/s41467-020-20190-4.
10
The Effect of Propofol on a Forced Swim Test in Mice at 24 Hours.丙泊酚对小鼠24小时强迫游泳试验的影响。
Curr Ther Res Clin Exp. 2020 Jun 14;92:100590. doi: 10.1016/j.curtheres.2020.100590. eCollection 2020.
本文引用的文献
1
Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling.氯胺酮诱导的糖原合酶激酶-3抑制作用有助于增强α-氨基-3-羟基-5-甲基异恶唑-4-丙酸（AMPA）受体信号传导。
Bipolar Disord. 2016 Sep;18(6):473-480. doi: 10.1111/bdi.12436. Epub 2016 Sep 30.
2
Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders.平衡氯胺酮治疗情绪障碍的前景与风险
Neuropsychopharmacology. 2017 May;42(6):1179-1181. doi: 10.1038/npp.2016.193. Epub 2016 Sep 19.
3
Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.在抑郁症社会挫败应激模型中R-氯胺酮与瑞帕斯汀抗抑郁作用的比较。
Psychopharmacology (Berl). 2016 Oct;233(19-20):3647-57. doi: 10.1007/s00213-016-4399-2. Epub 2016 Aug 4.
4
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.谷氨酸和γ-氨基丁酸系统在重度抑郁症病理生理学及对氯胺酮抗抑郁反应中的作用
Biol Psychiatry. 2017 May 15;81(10):886-897. doi: 10.1016/j.biopsych.2016.05.005. Epub 2016 May 12.
5
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.氯胺酮代谢物的非NMDAR抑制依赖性抗抑郁作用。
Nature. 2016 May 26;533(7604):481-6. doi: 10.1038/nature17998. Epub 2016 May 4.
6
The role of adipokines in the rapid antidepressant effects of ketamine.脂肪因子在氯胺酮快速抗抑郁作用中的作用。
Mol Psychiatry. 2017 Jan;22(1):127-133. doi: 10.1038/mp.2016.36. Epub 2016 Apr 5.
7
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.重度抑郁症中谷氨酸受体的治疗性调节
Curr Neuropharmacol. 2017;15(1):57-70. doi: 10.2174/1570159x14666160321123221.
8
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.抑郁症的新兴治疗机制：聚焦于谷氨酸与突触可塑性
Drug Discov Today. 2016 Mar;21(3):454-64. doi: 10.1016/j.drudis.2016.01.016. Epub 2016 Feb 6.
9
An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.一项关于氯胺酮抗疲劳作用的双盲、安慰剂对照、交叉研究，该研究针对双相情感障碍患者。
J Affect Disord. 2016 Apr;194:115-9. doi: 10.1016/j.jad.2016.01.009. Epub 2016 Jan 19.
10
New targets for rapid antidepressant action.快速抗抑郁作用的新靶点。
Prog Neurobiol. 2017 May;152:21-37. doi: 10.1016/j.pneurobio.2015.12.001. Epub 2015 Dec 23.
Zotero 插件